언어 선택
무료 등록

HLA-A*1101 & B2M & KRASG12R (VVVGARGVGK)

HLA-A*1101 & B2M & KRASG12R (VVVGARGVGK) 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • 종

    Human (1)

  • 태그

    His Tag & Avi Tag (1)

  • 마커

    Biotin-labeled (1)

제품 번호종발현 시스템제품 설명단백질 구조순도특성
HLR-H82E2
Human
HEK293
Biotinylated Human HLA-A*11:01&B2M&KRASG12R (VVVGARGVGK) Complex Protein (Monomer, MALS verified)
총 수량1
  • 1

HLA-A*1101 & B2M & KRASG12R (VVVGARGVGK)분자 배경

The peptide VVVGARGVGK, derived from the KRAS G12R mutation and presented by the HLA-A*11:01/β2-microglobulin (β2m) complex, is a pivotal antigenic target in antitumor immunity. This complex plays a crucial role by activating specific cytotoxic T lymphocytes (CTLs), enabling the immune system to recognize and eliminate tumor cells harboring the KRAS G12R mutation.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
BuntanetapANVS-405; ANVS-401Phase 3 ClinicalRaptor PharmaceuticalDown Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Parkinson Disease; Cognitive Dysfunction; Frontotemporal Dementia
상세
Florzolotau (Aprinoia Therapeutics)[18F]APN-1607; [18F]MNI-958; APN-0000455; F0-PBB3; PM-PBB3; [18F]PM-PBB3; APN-1607; 18F-PM-PBB3; 18F-APN-1607Phase 3 ClinicalAprinoia Therapeutics LtdSupranuclear Palsy, Progressive; Nerve Degeneration; Alzheimer Disease; Cognitive Dysfunction; Diagnostic agents; Cognition Disorders
상세
E-2814E-2814Phase 3 ClinicalEisai Co LtdDementia; Alzheimer Disease
상세
Izaflortaucipir F-18[18F]PI-2620; PI-2620; 18F-PI-2620Phase 3 ClinicalPiramal, Ac Immune SaHypotension; Supranuclear Palsy, Progressive; Brain Concussion; Opioid-Related Disorders; Frontotemporal Lobar Degeneration; Alzheimer Disease; Cognitive Dysfunction
상세
Leuco methylthioniniumLMT-X; TRX-0237; Leuco-MTx; LMTM; L-MTx; HMTMPhase 3 ClinicalTaurx PharmaceuticalsAlzheimer Disease; Cognitive Dysfunction; Frontotemporal Dementia
상세
XTR-006XTR-006Phase 3 ClinicalTauopathies; Alzheimer Disease
상세
ZagotenemabLY-3303560Phase 2 ClinicalEli Lilly And CompanyAlzheimer Disease
상세
PosdinemabJNJ-63733657; JNJ-3657Phase 2 ClinicalAlzheimer Disease; Cognitive Dysfunction; Dementia
상세
[18F]GTP-1[18F]GTP-1Phase 2 ClinicalGenentech IncAlzheimer Disease
상세
FluoroTau[18F]THK-5351; GE-216; F-18-THK-5351Phase 2 ClinicalTohoku UniversityKidney Neoplasms; Carcinoma, Renal Cell; Alzheimer Disease; Cognitive Dysfunction; Neurodegenerative Diseases; Diabetes Mellitus
상세
[18F]THK-5105[18F]THK-5105Phase 2 ClinicalTohoku UniversityAlzheimer Disease
상세
ISIS-814907BIIB-080; ISIS-814907; IONIS-MAPTRx; ISIS-BIIB4Rx; IONIS-BIIB4RXPhase 2 ClinicalBiogen Inc, Ionis Pharmaceuticals IncCognitive Dysfunction; Dementia; Alzheimer Disease
상세
TilavonemabC2N-8E12; ABBV-8E12Phase 2 ClinicalC2n Diagnostics LlcSupranuclear Palsy, Progressive; Alzheimer Disease
상세
Alzheimer's disease vaccine (Axon Neuroscience)AADvac-1Phase 2 ClinicalAxon BiochemicalsAlzheimer Disease; Primary Progressive Nonfluent Aphasia
상세
SemorinemabMTAU-9937A; MTAU9937A; RG-6100; RO7105705; RO-7105705Phase 2 ClinicalAc Immune SaAlzheimer Disease
상세
APN-1701[18F]AM-PBB3; 18F-AM-PBB3; APN-1701Phase 2 ClinicalNational Institute Of Radiological Sciences, Aprinoia Therapeutics LtdNerve Degeneration; Alzheimer Disease
상세
Anti-tau antibody (Prothena)PRX-005; BMS-986446Phase 2 ClinicalProthenaAlzheimer Disease; Frontotemporal Dementia
상세
BepranemabUCB-0107Phase 2 ClinicalUcbSupranuclear Palsy, Progressive; Alzheimer Disease
상세
[18F]THK-5117[18F]THK-5117Phase 2 ClinicalTohoku UniversityAlzheimer Disease
상세
PNT-001PNT-001Phase 1 ClinicalPinteon Therapeutics IncBrain Injuries, Traumatic; Alzheimer Disease
상세
ReS19-TReS19-TPhase 1 ClinicalRemyndAlzheimer Disease
상세
Mecripyrine HydrochlorideSCR-1693; Y-1A; Y-1Phase 1 ClinicalJiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, NeuroDawn Pharmaceutical Co LtdBrain Neoplasms; Alzheimer Disease
상세
Lu-AF87908Lu-AF87908; Lu-AF-87908Phase 1 ClinicalH. Lundbeck A/SAlzheimer Disease
상세
RDC-5RDC-5Phase 1 ClinicalAmyotrophic Lateral Sclerosis
상세
MC-1 (Lilly)MC-1 (Lilly)Phase 1 ClinicalEli Lilly And CompanyAlzheimer Disease
상세
OLX-07010OLX07010Phase 1 ClinicalOligomerix IncSupranuclear Palsy, Progressive; Alzheimer Disease; Dementia; Neurodegenerative Diseases
상세
ProtollinPhase 1 ClinicalBrigham and Women's Hospital IncAlzheimer Disease
상세
ADEL-Y01ADEL-Y01Phase 1 ClinicalOscotec Inc, ADEL IncTauopathies; Alzheimer Disease
상세
MK-2214MK-2214Phase 1 ClinicalMerck Sharp & Dohme LLCAlzheimer Disease
상세
APNmAb-005APNmAb-005Phase 1 ClinicalAprinoia Therapeutics LtdNerve Degeneration; Alzheimer Disease; Tauopathies
상세
NIO-752NIO-752Phase 1 ClinicalNovartis Pharma AgSupranuclear Palsy, Progressive; Cognitive Dysfunction; Alzheimer Disease; Neurodegenerative Diseases
상세
BEY-2153BEY-2153Phase 1 ClinicalBeyondbio IncAlzheimer Disease
상세
BIIB-076NI-105; BIIB-076Phase 1 ClinicalBiogen Inc, Neurimmune AgAlzheimer Disease
상세
11C-PBB311C-PBB3ClinicalNational Institute Of Radiological SciencesAlzheimer Disease
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Flortaucipir F1818F-AV-1451; T807; F-18-AV-1451ApprovedSiemens Medical SolutionTauvidUnited StatesAlzheimer DiseaseAvid Radiopharmaceuticals Inc2020-05-28Alzheimer Disease; Frontotemporal Dementia; Neurodegenerative Diseases; Cognition Disorders; Corticobasal degeneration; Cognitive Dysfunction; Dementia; Tauopathies; Parkinson Disease; Supranuclear Palsy, Progressive; Pick Disease of the Brain; Chronic Traumatic Encephalopathy; Aphasia, Primary Progressive; Brain Concussion; Brain Injuries, Traumatic; Depression; Brain Injuries
상세
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
공유하기:

참여하기법적 규정사이트맵개인정보 정책약관 및 조건
웹사이트 피드백
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

이메일
order.kr@acrobiosystems.com

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호